Literature DB >> 16699167

Characterization of GE82832, a peptide inhibitor of translocation interacting with bacterial 30S ribosomal subunits.

Letizia Brandi1, Attilio Fabbretti, Michele Di Stefano, Ameriga Lazzarini, Monica Abbondi, Claudio O Gualerzi.   

Abstract

GE82832, a secondary metabolite produced by Streptosporangium cinnabarinum (strain GE82832), has been identified as a translational inhibitor by in vitro screening of a library of natural products. Secondary functional tests specific for individual steps of the translational pathway demonstrated that translocation is the specific target of GE82832. Chemical probing in situ demonstrated that this antibiotic protects bases A1324 and A1333 and exposes C1336 of 16S rRNA, thereby indicating that its binding site is located on the head of the 30S ribosomal subunit. The ribosomal location of GE82832, near ribosomal protein S13 and G1338, two elements of the small subunit that are part of or close to the B1a intrasubunit bridge, suggests that translocation inhibition results from an altered dynamics of 30S-50S ribosomal subunit interaction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16699167      PMCID: PMC1484444          DOI: 10.1261/rna.61206

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  31 in total

1.  Factor-free ("non-enzymic") and factor-dependent systems of translation of polyuridylic acid by Escherichia coli ribosomes.

Authors:  L P Gavrilova; O E Kostiashkina; V E Koteliansky; N M Rutkevitch; A S Spirin
Journal:  J Mol Biol       Date:  1976-03-15       Impact factor: 5.469

2.  Rapid chemical probing of conformation in 16 S ribosomal RNA and 30 S ribosomal subunits using primer extension.

Authors:  D Moazed; S Stern; H F Noller
Journal:  J Mol Biol       Date:  1986-02-05       Impact factor: 5.469

3.  The translocation inhibitor tuberactinomycin binds to nucleic acids and blocks the in vitro assembly of 50S subunits.

Authors:  T Yamada; T Teshima; T Shiba; K H Nierhaus
Journal:  Nucleic Acids Res       Date:  1980-12-11       Impact factor: 16.971

4.  Conformational changes of the small ribosomal subunit during elongation factor G-dependent tRNA-mRNA translocation.

Authors:  Frank Peske; Andreas Savelsbergh; Vladimir I Katunin; Marina V Rodnina; Wolfgang Wintermeyer
Journal:  J Mol Biol       Date:  2004-11-05       Impact factor: 5.469

5.  Dinucleotide codon-anticodon interaction as a minimum requirement for ribosomal aa-tRNA binding: stabilisation by viomycin of aa-tRNA in the A site.

Authors:  R Lührmann
Journal:  Nucleic Acids Res       Date:  1980-12-11       Impact factor: 16.971

Review 6.  Molecular recognition of aminoglycoside antibiotics by ribosomal RNA and resistance enzymes: an analysis of x-ray crystal structures.

Authors:  Quentin Vicens; Eric Westhof
Journal:  Biopolymers       Date:  2003-09       Impact factor: 2.505

7.  An elongation factor G-induced ribosome rearrangement precedes tRNA-mRNA translocation.

Authors:  Andreas Savelsbergh; Vladimir I Katunin; Dagmar Mohr; Frank Peske; Marina V Rodnina; Wolfgang Wintermeyer
Journal:  Mol Cell       Date:  2003-06       Impact factor: 17.970

8.  Ribosomal proteins S12 and S13 function as control elements for translocation of the mRNA:tRNA complex.

Authors:  Anthony R Cukras; Daniel R Southworth; Julie L Brunelle; Gloria M Culver; Rachel Green
Journal:  Mol Cell       Date:  2003-08       Impact factor: 17.970

9.  Chloramphenicol, erythromycin, carbomycin and vernamycin B protect overlapping sites in the peptidyl transferase region of 23S ribosomal RNA.

Authors:  D Moazed; H F Noller
Journal:  Biochimie       Date:  1987-08       Impact factor: 4.079

10.  Study of the structural dynamics of the E coli 70S ribosome using real-space refinement.

Authors:  Haixiao Gao; Jayati Sengupta; Mikel Valle; Andrei Korostelev; Narayanan Eswar; Scott M Stagg; Patrick Van Roey; Rajendra K Agrawal; Stephen C Harvey; Andrej Sali; Michael S Chapman; Joachim Frank
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

View more
  8 in total

1.  Selection of small peptides, inhibitors of translation.

Authors:  Beatriz Llano-Sotelo; Dorota Klepacki; Alexander S Mankin
Journal:  J Mol Biol       Date:  2009-07-02       Impact factor: 5.469

2.  The antibiotics dityromycin and GE82832 bind protein S12 and block EF-G-catalyzed translocation.

Authors:  David Bulkley; Letizia Brandi; Yury S Polikanov; Attilio Fabbretti; Michael O'Connor; Claudio O Gualerzi; Thomas A Steitz
Journal:  Cell Rep       Date:  2014-01-09       Impact factor: 9.423

3.  Conformational changes of elongation factor G on the ribosome during tRNA translocation.

Authors:  Jinzhong Lin; Matthieu G Gagnon; David Bulkley; Thomas A Steitz
Journal:  Cell       Date:  2015-01-15       Impact factor: 41.582

Review 4.  Ribosome-Targeting Antibiotics: Modes of Action, Mechanisms of Resistance, and Implications for Drug Design.

Authors:  Jinzhong Lin; Dejian Zhou; Thomas A Steitz; Yury S Polikanov; Matthieu G Gagnon
Journal:  Annu Rev Biochem       Date:  2018-03-23       Impact factor: 27.258

5.  High-Quality Draft Genome Sequence of Sphaerisporangium cinnabarinum ATCC 31213.

Authors:  Line Friis Bakmann Christensen; Daniel Otzen; Morten Simonsen Dueholm
Journal:  Genome Announc       Date:  2018-05-24

6.  Characterization of the Self-Resistance Mechanism to Dityromycin in the Streptomyces Producer Strain.

Authors:  Attilio Fabbretti; Retina Çapuni; Anna Maria Giuliodori; Lucia Cimarelli; Antonino Miano; Valerio Napolioni; Anna La Teana; Roberto Spurio
Journal:  mSphere       Date:  2019-09-25       Impact factor: 4.389

Review 7.  Discovering new bioactive molecules from microbial sources.

Authors:  Paolo Monciardini; Marianna Iorio; Sonia Maffioli; Margherita Sosio; Stefano Donadio
Journal:  Microb Biotechnol       Date:  2014-03-24       Impact factor: 5.813

Review 8.  The Mechanisms of Action of Ribosome-Targeting Peptide Antibiotics.

Authors:  Yury S Polikanov; Nikolay A Aleksashin; Bertrand Beckert; Daniel N Wilson
Journal:  Front Mol Biosci       Date:  2018-05-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.